Skip to main content

Closed

PLYX: Polaryx Therapeutics, Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-190.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio3.45×

Polaryx Therapeutics, Inc. Common Stock

PLYXNASDAQ Global Market·USD·Closed

Polaryx Therapeutics, Inc. Common Stock

PLYXNASDAQ·USD·Closed

$2.31

+7.44%

$2.31

+$0.16 (7.44%)

52W Range

1thpctl

Volume

0.98×avg

Mkt Cap

115.14MUSD

P/E

-23.5TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.98×avg

Market Cap

115.14MUSD

P/E Ratio

-23.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings